1. A Phase I Trial of Vaccination of CA9-Derived Peptides for HLA-A24-Positive Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma
   Hirotsugu Uemura et al, 2006, Clinical Cancer Research CrossRef